A double-blinded randomised controlled study of the value of sequential intravenous and oral magnesium therapy in patients with chronic low back pain with a neuropathic component

Anaesthesia

Volumn 68, Issue 3, 2013, Pages 260-266

  Yousef, A A ^a   Al Deeb, A E ^a  

^a TANTA UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; CELECOXIB; GABAPENTIN; GLUCONATE MAGNESIUM; MAGNESIUM DERIVATIVE; MAGNESIUM OXIDE; MAGNESIUM SULFATE; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; PLACEBO; TRAMADOL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BEDTIME DOSAGE; CHRONIC PAIN; COHORT ANALYSIS; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG RESPONSE; DRUG TREATMENT FAILURE; FEMALE; FOLLOW UP; HUMAN; LOW BACK PAIN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; NEUROPATHIC PAIN; PAIN ASSESSMENT; PHYSIOTHERAPY; RANDOMIZED CONTROLLED TRIAL; RANGE OF MOTION; RATING SCALE; TREATMENT DURATION;

ADMINISTRATION, ORAL; ANALGESICS; CHRONIC DISEASE; COHORT STUDIES; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFUSIONS, INTRAVENOUS; LOW BACK PAIN; LUMBAR VERTEBRAE; MAGNESIUM SULFATE; MALE; MIDDLE AGED; NEURALGIA; PAIN; PAIN MEASUREMENT; PERIPHERAL NERVOUS SYSTEM DISEASES; RANGE OF MOTION, ARTICULAR; TREATMENT OUTCOME;

EID: 84873422814     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/anae.12107     Document Type: Article

References (25)

1. Dick BD, Rashiq S,. Disruption of attention and working memory traces in individuals with chronic pain. Anesthesia and Analgesia 2007; 104: 1223-9.
2. Liszka JJ, Martin DP,. An analysis of the relationship between activity and pain in chronic and acute low back pain. Anesthesia and Analgesia 2004; 99: 477-81.
3. Freynhagen R, Baron R,. The evaluation of neuropathic components in low back pain. Current Pain and Headache Reports 2009; 13: 180-90.
4. Woolf CJ, Mannion RJ,. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 1999; 353: 1959-64.
5. Pan HL, Eisenach JC, Chen SR,. Gabapentin suppresses ectopic nerve discharges and reserves alloying in neuropathic rats. Journal of Pharmacology and Experimental Therapeutics 1999; 288: 1026-30.
6. Pleasure DE,. Advances in neuropathic pain. Diagnosis, mechanism and treatment recommendations. Archives of Neurology 2003; 60: 1524-34.
7. Begon S, Pickering G, Eschalier A, Dubray C,. Magnesium increases morphine analgesic effect in different experimental models of pain. Anesthesiology 2002; 96: 627-32.
8. Kleinbohl D, Gortelmeyer R, Hans-Joachim B, Holzl R,. Amantidine sulfate reduces experimental sensitization and pain in chronic pain patients. Anesthesia and Analgesia 2006; 102: 840-7.
9. Felsby S, Nielsen J, Arendt-Nielsen L, Jensen TS,. NMDA receptor blockade in chronic neuropathic pain: a comparison of ketamine and magnesium chloride. Pain 1995; 64: 283-91.
10. Woolf CJ, Thompson WN,. The induction and maintenance of central sensitisation is dependent on N-methyl-D-aspartic acid receptor activation: implications for the treatment of post-injury pain hypersensitivity states. Pain 1991; 44: 298-9.
11. Bennett M,. The LANNS pain scale. The Leeds assessment of neuropathic symptoms and signs. Pain 2001; 92: 147-57.
12. Grosby V, Wilcock A, Cotcoran R,. The safety and efficacy as a single (500mg or 1g) of intravenous magnesium sulfate in neuropathic pain poorly responsive to strong opioid analgesics in patients with cancer. Journal of Pain and Symptom Management 2000; 19: 35-9.
13. Brill S, Sedgwick PM, Hamann W, di Vadi PP,. Efficacy of intravenous magnesium in neuropathic pain. British Journal of Anaesthesia 2002; 89: 711-4.
14. Warner DS, Herroeder S, Schönherr ME, De Hert SG, Hollmann MW,. Magnesium-essentials for anesthesiologists. Anesthesiology 2011; 114: 971-93.
15. Okon T,. Ketamine: an introduction for the pain and palliative medicine physician. Pain Physician 2007; 10: 439-500.
16. Baranowski P, Adamczyk A,. The implantation of continuous ketamine infusion in neuropathic pain syndrome. Advances in Palliative Medicine 2007; 6: 87-92.
17. Guzmán J, Esmail R, Karjalainen K, Malmivaara A, Irvin E, Bombardier C,. Multidisciplinary rehabilitation for chronic low back pain: systematic review. British Medical Journal 2001; 322: 1511-6.
18. Smeets RJ EM, Vlaeyen JWS, Hidding A, et al. Active rehabilitation for chronic low back pain: cognitive-behavioral, physical, or both? First direct post-treatment results from a randomized controlled trial. BMC Musculoskeletal Disorders 2006; 7: 5.
19. Hasegawa AE, Zacny JP,. The influence of three L-type calcium channel blockers on morphine effects in healthy volunteers. Anesthesia and Analgesia 1997; 85: 633-8.
20. Iseri LT, French JH,. Magnesium: nature's physiologic calcium blocker (1984). American Heart Journal 1984; 108: 188-93.
21. Czarnetzki C, Lysakowski C, Elia N, Tramer MR,. Time course of rocuronium-induced neuromuscular block after pre-treatment with magnesium sulphate: a randomized study. Acta Anaesthesiologica Scandinavica 2010; 54: 299-306.
22. Koinig H, Wallner T, Marhofer P, Andel H, Horauf K, Mayer N,. Magnesium sulfate reduces intra- and postoperative analgesic requirements. Anesthesia and Analgesia 1998; 87: 206-10.
23. Tramer RM, Schneider J, Marti RA, Rifat K,. Role of magnesium sulphate in postoperative analgesia. Anesthesiology 1996; 84: 340-7.
24. Hwang JY, Na HS, Jeon YT, Ro YJ, Kim CS, Do SH,. I.V. infusion of magnesium sulphate during spinal anaesthesia improves postoperative analgesia. British Journal of Anaesthesia 2010; 104: 89-93.
25. Apan A, Buyukkocak U, Ozcan S, Sari E, Basar H,. Postoperative magnesium sulphate infusion reduces analgesic requirements in spinal anesthesia. European Journal of Anaesthesiology 2004; 21: 766-9.